Evidence map›Paper›PMID 42823661›Full record

ArticleMolecular medicine (Cambridge, Mass.)2026

Fibroblast-associated protection against hypoxia and carboplatin-induced cytotoxicity during coculture with osteosarcoma.

Hans Zoellner, Duan Ni, Jhati Kakani, Jingyi Zhou, Brigitta Sabrina Auwyang, Yogambha Ramaswamy, Belal Chami

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hans ZoellnerThe Cellular and Molecular Pathology Research Unit, Discipline of Oral Pathology and Oral Medicine, Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Westmead Hospital, Sydney, NSW, 2145, Australia.
Duan NiSydney Medical School Nepean, The University of Sydney, Sydney, NSW, Australia.
Jhati KakaniThe Cellular and Molecular Pathology Research Unit, Discipline of Oral Pathology and Oral Medicine, Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Westmead Hospital, Sydney, NSW, 2145, Australia.
Jingyi ZhouThe Cellular and Molecular Pathology Research Unit, Discipline of Oral Pathology and Oral Medicine, Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Westmead Hospital, Sydney, NSW, 2145, Australia.
Brigitta Sabrina AuwyangThe Cellular and Molecular Pathology Research Unit, Discipline of Oral Pathology and Oral Medicine, Sydney Dental School, Faculty of Medicine and Health, The University of Sydney, Westmead Hospital, Sydney, NSW, 2145, Australia.
Yogambha RamaswamyGraduate School of Biomedical Engineering, University of NSW, Sydney, NSW, 2052, Australia.
Belal ChamiRedox Inflammation Group, Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Level 4 West, Sydney, NSW, 2006, Australia. belal.chami@sydney.edu.au.ORCID https://orcid.org/0000-0002-8491-8614

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteosarcoma progression and treatment resistance are strongly influenced by the tumour microenvironment. One of the key players in tumour microenvironments is cancer-associated fibroblast. Much of the conventional cancer-associated fibroblast-centred research paradigm focuses on the secretory and matrix-remodelling aspects of fibroblasts. However, less is known on how fibroblasts influence osteosarcoma cell behaviour, particular under stress.

methodsIn a proof-of-concept study, human dermal fibroblasts and osteosarcoma cells were studied using direct coculture and size-restricted transwell systems. Fluorescent labelling, confocal microscopy, live-cell imaging, and single-cell tracking were used to assess intercellular transfer, migratory behaviour, proliferation, and survival under chemotherapy and hypoxic challenge.

resultsOsteosarcoma cells acquired fibroblast-derived, mitochondria cargo-enriched material in both direct and indirect coculture systems, with transfer of material enhanced under carboplatin and hypoxic stress. Notably, fibroblast coculture increased osteosarcoma cell migration and promoted survival under stress but did not substantially increase basal proliferation.

conclusionsThese findings suggest that fibroblast-to-cancer cell transfer of mitochondria-enriched cargo is accelerated during stress conditions with the concomitant observation of proportional osteosarcoma protection to degree of fibroblast cargo transfer. Further research should examine stress-amplified transfer during tumour adaptation, chemoresistance, and metastatic behaviour, potentially highlighting stromal intercellular communication as an important aspect of osteosarcoma biology.

Indexed as

Antineoplastic AgentsBone NeoplasmsCarboplatinFibroblastsOsteosarcomaCancer-Associated FibroblastsCell CommunicationCell HypoxiaCell Line, TumorCell MovementCell ProliferationCell SurvivalCoculture TechniquesHumansMitochondriaTumor MicroenvironmentAntineoplastic AgentsCarboplatinCancer-associated fibroblastChemoresistanceMitochondrial transferOsteosarcomaStress adaptationTumour microenvironment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.